ES348973A1 - Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same - Google Patents

Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same

Info

Publication number
ES348973A1
ES348973A1 ES348973A ES348973A ES348973A1 ES 348973 A1 ES348973 A1 ES 348973A1 ES 348973 A ES348973 A ES 348973A ES 348973 A ES348973 A ES 348973A ES 348973 A1 ES348973 A1 ES 348973A1
Authority
ES
Spain
Prior art keywords
succinimide
propargyl
relating
new
preparing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES348973A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAB AUCLAIR
Original Assignee
LAB AUCLAIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAB AUCLAIR filed Critical LAB AUCLAIR
Publication of ES348973A1 publication Critical patent/ES348973A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

The novel compound of formula and acid addition salts thereof are prepared by reaction of N-propargyl-succinimide and hexamethylenimine with formaldehyde or trioxymethylene optionally followed by salt formation. N - propargyl - succinimide is prepared by reaction of succinimide and a propargyl ester. Pharmaceutical compositions having an effect on the central nervous system particularly as an anticholinergenic agent and in conventional forms for oral or parenteral administration comprise an above novel compound or a salt thereof and one or more carriers or diluents.
ES348973A 1967-01-06 1968-01-05 Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same Expired ES348973A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR90164A FR6369M (en) 1967-01-06 1967-01-06

Publications (1)

Publication Number Publication Date
ES348973A1 true ES348973A1 (en) 1969-03-16

Family

ID=8623457

Family Applications (1)

Application Number Title Priority Date Filing Date
ES348973A Expired ES348973A1 (en) 1967-01-06 1968-01-05 Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same

Country Status (8)

Country Link
AT (1) AT273091B (en)
BE (1) BE708558A (en)
CH (1) CH484925A (en)
DE (1) DE1695379A1 (en)
ES (1) ES348973A1 (en)
FR (1) FR6369M (en)
GB (1) GB1180250A (en)
NL (1) NL6800223A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1314557A (en) * 1969-12-02 1973-04-26 Astra Laekemedel Ab Oxotremorine antagonists and methods for their preparation

Also Published As

Publication number Publication date
AT273091B (en) 1969-07-25
CH484925A (en) 1970-01-31
BE708558A (en) 1968-05-02
DE1695379A1 (en) 1970-09-10
FR6369M (en) 1968-10-14
NL6800223A (en) 1968-07-08
GB1180250A (en) 1970-02-04

Similar Documents

Publication Publication Date Title
GB1173227A (en) Amino-Isoquinolines
SE8003351L (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC SOCIETIES WITH THERAPEUTIC EFFECT
ES348973A1 (en) Improvements in or relating to New But-2-Yne Derivative and Process for Preparing same
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
GB1299201A (en) Medicaments derived from thiazolidine carboxylic acid
ES354173A1 (en) Tetracycline sulfamate and derivatives thereof
GB1142508A (en) Pyrrole derivatives
GB1351526A (en) Tropan-3-ol derivatives and processes for their preparation
GB1184826A (en) Substituted Aryloxy Hydroxy Amines
ES364980A1 (en) A method for preparing new adamantan derivatives. (Machine-translation by Google Translate, not legally binding)
GB1244881A (en) New piperidine derivatives, process for their production and preparations containing same
ES338660A1 (en) 4-(2'-tetrahydrofurfuryloxy carbonyl)-phenylamino-chloro-quinolines
GB1238416A (en)
GB1223445A (en) Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
GB1318859A (en) Imidazo-4,5-b-pyridine derivatives
GB1131126A (en) 2-vinyl-1,4-dihydroquinazoline derivatives
ES286809A1 (en) Novel benzoxazepine derivatives and a process for the manufacture thereof
GB1173577A (en) Improvements in or relating to New Indole Derivatives, Process for Preparing same and Therapeutic Compositions Containing them
GB1315575A (en) Schiffs bases from 2-aminoimidazole derivatives and the preparation thereof
GB1341612A (en) Theophylline isobutyrate salts and process for the preparation thereof
GB1103155A (en) Improvements in and relating to quinazolines
ES401174A1 (en) 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor
GB1264944A (en)
GB1211387A (en) 0-benzylpiperidine derivative and a process for the preparation thereof
ES369889A1 (en) Quinoxaline-1,4-dioxides